发明名称 Organic Compounds
摘要 The present invention relates to compounds that are useful to inhibit, regulate and/or modulate tyrosine and serine/threonine kinase and kinase-like proteins, such as RAF kinase, a serine/threonine kinase that functions in the MAP kinase signaling pathway. The application is also concerned with compositions which contain these compounds, and methods of using them to treat tyrosine and serine/threonine kinase and kinase-like dependent diseases, such as angiogenesis, cancer and cardiac hypertrophy, and with other subject matter.
申请公布号 US2009306107(A1) 申请公布日期 2009.12.10
申请号 US20060908913 申请日期 2006.03.17
申请人 NOVARTIS AG 发明人 PEREZ LAWRENCE BLAS;SHENG TAO
分类号 A61K31/519;A61P35/00;C07D471/04 主分类号 A61K31/519
代理机构 代理人
主权项
地址